Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08VXO
|
||||
Former ID |
DAP001066
|
||||
Drug Name |
Brompheniramine
|
||||
Synonyms |
Bromfed; Bromfenex; Bromfeniramina; Brompheniraminum; Brotane; Parabromdylamine; BROMFED-DM; Bromfeniramina [INN-Spanish]; Brompheniramine (INN); Brompheniramine [INN:BAN]; Brompheniraminum [INN-Latin]; Brotane (TN); DIMETANE-DX; P-Bromdylamine; Para-Bromdylamine; Brompheniramine Maleate (1:1); [3-(4-Bromophenyl)-3-(2-pyridyl)propyl]dimethylamine; Gamma-(4-Bromophenyl)-N,N-dimethyl-2-pyridinepropanamine; 1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-(p-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine; 3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine; 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; 3-(p-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antiallergic Agents
|
||||
Company |
Alpharma Us Pharmaceuticals Division
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H19BrN2
|
||||
InChI |
InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
|
||||
InChIKey |
ZDIGNSYAACHWNL-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 86-22-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9075, 615216, 6677389, 7978822, 8154449, 10537061, 11342021, 11362204, 11364576, 11367138, 11369700, 11371960, 11374692, 11377862, 11466503, 11467623, 11485355, 11486285, 11487606, 11489426, 11490796, 11492921, 11495496, 15396259, 29225774, 46508137, 47248568, 47397182, 47397183, 47472595, 47472596, 47546820, 47768508, 47991967, 47991968, 48291421, 48415651, 49698955, 50031272, 50065321, 50070760, 50105249, 50892257, 51091865, 85209729, 85788883, 90341200, 92714616, 92729935, 96099913
|
||||
SuperDrug ATC ID |
R06AB01
|
||||
SuperDrug CAS ID |
cas=000086226
|
||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [537912] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References | |||||
Ref 538351 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 083821. | ||||
Ref 542140 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7133). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.